|
| Group A | Group B | Total | p value |
n |
| 63 | 68 | 131 | - |
Age (median) |
| 67 | 66 | 66 | - |
Gender | Male | 43 | 56 | 99 | 0.069 |
| Female | 20 | 12 | 32 | |
Histology | Adenocarcinoma | 31 | 24 | 55 | 0.115 |
| Squamous Cell Carcinoma | 29 | 44 | 73 | |
| Other | 3 | 0 | 3 | 0.108 |
ASA | I | 1 | 1 | 2 | 1 |
| II | 9 | 8 | 17 | 0.796 |
| III | 51 | 57 | 108 | 0.819 |
| IV | 2 | 2 | 4 | 1 |
Surgery | Wedge Resection | 6 | 1 | 7 | 0.055 |
| Segmental Resection | 1 | 0 | 1 | 0.481 |
| Sleeve Resection | 3 | 1 | 4 | 0.351 |
| Lobectomy | 48 | 46 | 94 | 0.333 |
| Bilobectomy | 4 | 5 | 9 | 1 |
| Pneumonectomy | 2 | 14 | 16 | 0.002* |
UICC Stage | I | 38 | 25 | 63 | 0.009* |
| II | 8 | 24 | 32 | 0.004* |
| III | 17 | 19 | 36 | 1 |
Lymphadenectomy | Local | 4 | 2 | 6 | 0.427 |
| Systematic | 5 | 9 | 14 | 0.403 |
| 1 Station | 17 | 10 | 27 | 0.089 |
| 2 Stations | 29 | 20 | 49 | 0.070 |
| 3 Stations | 13 | 22 | 35 | 0.167 |
| 4 Stations | 4 | 13 | 27 | 0.0376* |
| 5 Stations | 0 | 2 | 2 | 0.497 |
| pN0 | 48 | 31 | 79 | 0.0003* |
| pN1 | 8 | 23 | 31 | 0.019* |
| pN2 | 7 | 13 | 20 | 0.23 |
| pN3 | 0 | 1 | 1 | 1 |